3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
6
Pancreatic Neoplasms
3
Pancreatic Cyst
2
Breast Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Thyroid Nodule
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neuroendocrine Tumor
1
Hyperthyroidism
1
Hip Fractures
1
Hematologic Neoplasms
1
Goiter
1
Glioma
1
Glioblastoma
1
Frailty
1
Fractures, Spontaneous
1
Interventions
pirtobrutinib
6
Cyclophosphamide
6
Mycophenolic Acid
5
fludarabine phosphate
4
fludarabine
4
Rituximab
4
Melphalan
4
Azacitidine
4
venetoclax
3
ibrutinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Mesna
3
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Lenalidomide
2
Cyclosporine
2
Busulfan
2
Brentuximab Vedotin
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Bendamustine Hydrochloride
2
zanubrutinib
1
ruxolitinib
1
ponatinib
1
pembrolizumab
1
nilotinib
1
idelalisib
1
idecabtagene vicleucel
1
cedazuridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Data Collection
×
1 year
×
Clear all
No trials found.